Free Trial

Curaleaf (OTCMKTS:CURLF) Stock Price Up 8.2% - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. (OTCMKTS:CURLF) saw its stock price increase by 8.2% to $1.54 during trading, despite an 81% decline in daily trading volume.
  • The company's recent earnings report showed a loss of ($0.07) per share, in line with analyst expectations, with a forecast of -0.25 earnings per share for the current year.
  • Curaleaf operates primarily in the cannabis sector, offering a range of products including flower, concentrates, and edibles across its domestic and international segments.
  • Want stock alerts on Curaleaf? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price traded up 8.2% during mid-day trading on Monday . The stock traded as high as $1.62 and last traded at $1.54. 119,050 shares were traded during mid-day trading, a decline of 81% from the average session volume of 630,615 shares. The stock had previously closed at $1.42.

Curaleaf Stock Performance

The company has a market cap of $1.33 billion, a PE ratio of -6.22 and a beta of 0.69. The company has a current ratio of 1.41, a quick ratio of 0.70 and a debt-to-equity ratio of 1.08. The business's 50 day moving average is $1.05 and its two-hundred day moving average is $1.05.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.41%. On average, equities research analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Further Reading

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines